2m 2m 2m 2m 2m 2m 2m
ENGENE THERAP (ENGN)
NASDAQ
$1.94-$0.04 (-2.27%)
Price as of Oct 02, 2026 4:10 PM EDT- $132.7MMarket Cap
- -75.68%1-Year Change
- BiotechnologyIndustry
ENGENE THERAP (ENGN)
$1.94-$0.04 (-2.27%)
ENGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.98 | ||
Change | -$0.02 (-1.00%) | ||
Open | $2.01 | ||
High | $2.01 | ||
Low | $1.96 | ||
Previous Close | $2.00 | ||
Volume | 903,044 | ||
30-Day Average Volume | 750,733 | ||
1-Week Change | 3.13% | ||
1-Month Change | 6.74% | ||
1-Year Change | -75.68% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.0M | ||
Total Assets | $288.3M | ||
Market Cap | $132.7M | ||
Enterprise Value | $117.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.5M | ||
Free Cash Flow | -$18.9M | ||
EBIT | -$31.7M | ||
EBITDA | -$31.5M | ||
Net Working Capital | $250.7M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 08/03/2015 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue